⌘K

16:22:02·715d

SECFilingvia Quantisnow

Kymera Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure

ByQuantisnow·Wall Street's wire, on your screen.

KYMR· Kymera Therapeutics Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Director Booth Bruce sold $3,299,037 worth of shares (31,798 units at $103.75) as part of a pre-agreed trading plan (SEC Form 4)
Director Booth Bruce exercised 11,741 shares at a strike of $20.00 and sold $45,293,294 worth of shares (478,198 units at $94.72) as part of a pre-agreed trading plan (SEC Form 4)
Chief Business Officer Goodman Noah exercised 2,500 shares at a strike of $21.05 and sold $247,500 worth of shares (2,500 units at $99.00) as part of a pre-agreed trading plan (SEC Form 4)
SEC Form 144 filed by Kymera Therapeutics Inc.
SEC Form 144 filed by Kymera Therapeutics Inc.